rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2004-9-1
|
pubmed:abstractText |
T-cell-rich B-cell lymphoma is a rare variant of diffuse large B-cell lymphoma. It shows morphologic, phenotypic and molecular similarities to lymphocyte predominant Hodgkin's disease, and in consequence the two diseases may sometimes be difficult to distinguish. In this paper, we have evaluated the usefulness of the pan-leukocyte marker LSP1 and the transcription factor PU.1 for resolving such diagnostic problems.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1592-8721
|
pubmed:author |
pubmed-author:AscaniStefanoS,
pubmed-author:ElenaSabattiniS,
pubmed-author:FaliniBrunangeloB,
pubmed-author:JaffeElaine SES,
pubmed-author:Müller-HermelinkHans-KonradHK,
pubmed-author:ManciniCristinaC,
pubmed-author:MarafiotiTeresaT,
pubmed-author:MasonDavid YDY,
pubmed-author:PileriStefano ASA,
pubmed-author:PozzobonMichelaM,
pubmed-author:PulfordKarenK,
pubmed-author:ZinzaniPier LuigiPL
|
pubmed:issnType |
Electronic
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
957-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15339679-Adult,
pubmed-meshheading:15339679-Antibodies,
pubmed-meshheading:15339679-Diagnosis, Differential,
pubmed-meshheading:15339679-Female,
pubmed-meshheading:15339679-Hodgkin Disease,
pubmed-meshheading:15339679-Humans,
pubmed-meshheading:15339679-Immunohistochemistry,
pubmed-meshheading:15339679-Lymphoma, B-Cell,
pubmed-meshheading:15339679-Major Histocompatibility Complex,
pubmed-meshheading:15339679-Male,
pubmed-meshheading:15339679-Neoplasm Staging,
pubmed-meshheading:15339679-Organic Anion Transport Polypeptide C,
pubmed-meshheading:15339679-Proto-Oncogene Proteins,
pubmed-meshheading:15339679-T-Lymphocytes,
pubmed-meshheading:15339679-Trans-Activators
|
pubmed:year |
2004
|
pubmed:articleTitle |
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
|
pubmed:affiliation |
Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|